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A knowledge of the site of action of antilymphocyte serum is required in order to 
develop a meaningful in vitro assay of its immunosuppressive activity and to gain 
insight into its mechas~ism of action. Mice treated with antilymphocyte serum exhibit 
defects similar in  nature to those characteristically found in neonatally thymecto- 
mized mice. Thus,  in  general,  cell-mediated immune responses are depressed to a 
greater extent than humoral antibody responses (1,  2)  and cell depletion  involves 
particularly that class of lymphocytes found in the periarteriolar lymphocyte sheaths 
of the spleen and diffuse cortex of the lymph nodes (1-4), that is in those areas tra- 
versed by long-rived  recirculating small lymphocytes (5). The question may thus be 
raised as to whether antilymphocyte serum might act selectively on a population of 
lymphocytes the development of which is under thymus control. 
The previous papers of this series have indicated that the IgM response of mice to 
sheep erythrocytes requires an interaction between thymus-derived antigen-reactive 
cells and bone marrow-derived antibody-forming cell  precursors  (6, 7).  Neonatally 
thymectomized mice challenged  with sheep red blood cells fail to produce in their 
spleens a normal number of hemolysin-forming cells (8). This deficiency can be cor- 
rected by injecting either thoracic duct cells (6, 8) or thymus cells (6). The restorative 
capacity of thymus cells clearly identifies  the specific cellular defect induced by thy- 
mectomy since the cell population of the thymus, unlike that of thoracic duct lymph, 
contains no antibody-forming cell precursors (7). 
Antilymphocyte  serum  depresses  the  immune  response  of  mice  to  sheep 
erythrocytes (9, 10).  If the target cells of antilymphocyte serum were primarily 
thymus-derived cells,  then normal reactivity should be restored by injecting 
thymus ceils. Accordingly, experiments were set up to test this possibility. In 
addition,  an investigation was made on the influence of thymus cells  on the 
response of heavily irradiated mice to an injection of sheep red blood cells and 
spleen cells from antilymphocyte serum-treated mice. 
* This is publication 1250, from The Waiter and Eliza Hall Institute of Medical Research. 
Supported by the  National  Health  and  Medical Research Council of Australia, the 
Australian Research Grants  Committee, the  Damon Runyon  Memorial Fund  for Cancer 
Research, the Jane Coffin Childs Memorial Fund for Medical Research, and the Anna Fuller 
Fund. 
855 856  CELL  TO  CELL  INTERACTION  IN  I'M'~UNE  RESPONSE.  IV 
Materials and Methods 
Mice.--2-  to 3-month-old  male and  female mice of the highly inbred  CBA strain  were 
used. The origin and maintenance of these mice has been described previously (6). 
Cell suspensions from spleen and thymus were prepared as before (6).  Sheep erythrooytes 
were obtained from a single sheep assigned to this work as reported in a previous paper (6). 
Injections were made either intraperitoncally or intravenously into the tail vein as stated 
in the text. In the case of thymus cells, in doses exceeding 10 million per mouse, intravenous 
injections were given slowly,  over 1-2 rain, and in a  large volume (0.4-0.5  ml) as reported 
before (6). 
Irradiation.--Mice were exposed  to doses of 800 fads total-body irradiation as explained 
in a  previous paper  (7). 
Thymectomy was performed by the method of Miller (11). Routine macroscopic and micro- 
seopic checks of thymus areas were made at autopsy and mice with thymus remnants were 
excluded from the experiments. 
Immunization and Assay for  Hemolysin Plaque-Forming Cdgs.--Mice were  immunized 
with 0.1 ml of a 20% suspension  of sheep erythrocytes (approximately 1-2 X  108 cells) either 
intmperitoneally or intravenously. The number of hemolysin plaque-forming ceils per spleen 
was determined according to the technique of Cunningham  and  Szenberg (12) which is a 
modification of that of Jeme et al.  (13). 
Preparation of Antilymphocyte Globulin (ALG).I--Two  preparations of rabbit  anti-mousc 
lymphocyte globulin were used. The first,  (A), was obtained from four rabbits by giving two 
injections of 109 washed thymus cells intravenously 14 days apart,  followed by two further 
injections of 5  X  10  s thymus cells 4 and 6 wk later. The rabbits were bled 7 days after the 
last injection. The ability of the preparation to prolong the survival of skin grafts on mice 
has been described previously (14). The second,  (B), was obtained from three rabbits by in- 
jecting 109 washed  mouse thymus cells intravenously at two-weekly intervals. The rabbits 
were bled  1 wk after both  the second  and  the third  injections and  the sera pooled. Both 
preparations were absorbed with washed mouse erythrocytes and the second preparation was 
also  absorbed  with  sheep  erythrocytes.  Neither  antisera  contained  detectable  antibodies 
against mouse gamma globulin.  2 The gamma globulin fraction of both  ~  sera was obtained by 
ammonium sulfate precipitation and passage through a DEAE-cellulose column using 0.0175 
M phosphate buffer pH 6.3. NRG was prepared slmil~rly.  The final products were adjusted to 
10 mg/ml and their purity checked by polyacrylamide gel electrophoresis and agar gel pre- 
cipitation using anti-rabbit gamma globulin antiserum. Mice received a single intraperitoneal 
injection of 5 mg ALG or NRG. 
Labeling of Thymus Cells with 51Cr.--Thymus ceils were washed once and then suspended 
in Eisen's balanced salt solution containing 10%  heat-inactivated fetal calf serum. The cell 
concentration was 5  X  107/ml.  SlCr, as Na2CrO4 in isotonic saline, was  obtained  from  the 
Radiochemical Centre, Amersham, England.  The specific  activity varied between 150  and 
263 p~//zg of chromium. The concentration of radioactivity was 1000#e/mi at the time of use. 
20/zc of radioactivity was added per milliliter of the cell suspension.  The  ceils were  then 
incubated in a water bath for 30 min at 37°C with occasional mixing. Cold Eisen's solution plus 
fetal calf serum was added and the tubes centrifuged. The cells were washed three times and 
finally resuspended in a concentration of about l0  s cells per milliliter. The amount of activity 
1 The following abbreviations are used: ALS, antllymphocyte serum; ALG, antilymphocyte 
globulin; NRG, normal rabbit globulin; SRBC, sheep erythrocytes; PFC, hemolysin plaque- 
forming cells;  NS, not significant; and  SE, standard  error. 
2 Assayed by the sensitive microprecipitation technique using a range of 1~I-labded mouse 
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in a sample was determined and mice were then injected with about 5 X 107 cells containing 
5000 counts per minute. 6 hr later the mice were bled and the spleens, livers, and lungs re- 
moved  for organ  counting. The amount of radioactivity  present in these organs  was determined 
using a Packard 'q'ricarb" scintillation counter. 
S~is~c~ A.alysis.--The standard errors of the means were calculated. The P  values 
were determined by Student's t test except where the variance ratio F test exceeded 0.05 
probability. An appropriate modification of the t test was then utilized,  s 
RESULTS 
Effect  of Antilymphocyte  Globulin on  the  Hemolysin  Plaque-Forming  Cell 
Response  to  Sheep  Erythrogytes.--The  immunosuppressive  capacity  of  our 
ALG preparations  was tested in mice challenged with SRBC.  In Fig.  1 are 
shown the results of experiments in which the animals were injected intraperi- 
toneally with SRBC 48 hr after administration of 5 mg ALG/A. The controls 
were  treated in  an identical way but received NRG instead  of ALG, or no 
rabbit globulin at all.  In all groups the peak number of PFC produced in the 
spleen occurred on day 4 but it was 1 log10 lower in the case of ALG-treated 
mice. 
Another group of mice was then used to determine when, in relation to the 
challenge with SRBC, the ALG preparation should be given in order to get a 
maximum immunosuppressive effect. The time of administration of ALG and 
NRG was  therefore varied  relative  to the  injection of SRBC  and  the  PFC 
response  per  spleen was determined  on day 4.  As can be  seen from Fig.  2, 
ALG exerted  significant immunosuppression but  only when  given before  or 
simultaneously with the SRBC. By contrast NRG, whether given before, or 
together with SRBC, produced no depression of the PFC response. 
Effects  of Antilymphocyte  Globulin on Hemolysin  Plaque--Forming Cells In 
Vitro.--Since  the  incubation  of  spleen  cells  containing  PFC  with  specific 
anti-H2 isoanfisera  and  complement in vitro was  associated with  a  marked 
reduction in the number of detectable PFC (6),  it was of interest to determine 
whether incubation with ALG would produce a  similar effect. Therefore,  10 
million  spleen  cells  from an immunized mouse were incubated with varying 
tu 
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concentrations of ALG in the presence of 1:10 guinea pig serum as a source of 
complement. For controls, cells were incubated under similar conditions but in 
the absence of ALG. After 30 min at 37°C, the number of PFC remaining was 
determined and expressed as a percentage of the number remaining in the ab- 
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DAYS  AFTER  SRBC INJECTION 
b-~G. 1. PFC produced in the spleens of normal mice (O  O) and of mice given a single 
dose  of  ALG  (O  O)  or N'RG  (I------ll) 48 hr prior to an intmperitoneal injection of 
SRBC. Each point represents the mean of determinations on four to six mice. The SE of the 
means are indicated by the vertical bars. 
sence  of ALG.  At concentrations  of  100  #g/ml  or less,  neither  ALG/A  nor 
ALG/B  inhibited  PFC.  Even  at  1  mg/ml,  only ALG/B  had  an  inhibitory 
effect (Fig. 3). 
Effect of Injecting  Th~rtnus Cells into ALG-treated M~ce.--The effect of ad- 
ministering thymus  cells on  the  immune  response  of ALG-treated mice  was 
examined. It was found  that an intravenous  injection of  100  million thymus 
cells had  no  effect on  the  response  of ALG/A-treated mice receiving SRBC 
intraperitoneatly although some increase was apparent in the case of ALG/B- W.  J.  MARTIN  AND  J.  1~.  A.  P.  MILLER  859 
treated recipients (Table I). When the erythrocytes were given intravenously 
together  with  thymus  cells,  a  marked  increase  in  the  response  occurred  in 
both ALG/A- and ALG/B-treated mice (Table I and Fig. 4). A similar increase 
was achieved with 20 million normal spleen cells given intravenously (Fig. 4 
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RELATIVE  TO  SRBC  INJECTION 
FIG. 2. PFC produced in the  spleens of normal mice (C on abscis~)  (O) and  of mice 
given a single dose of ALG (e) or NRG (n) at varying times relative to an intmperitoneal 
injection of SRBC. 
and Table II), whereas 100 million bone marrow cells had no significant effect 
(Table II). In addition, it can readily be seen from Table I that the response of 
ALG-treated mice not receiving thymus cells was greater when SRBC  were 
given intravenously than intraperitoneally.  In normal mice, however, neither 
thymus cells nor the route of injection of SRBC materially affected the PFC 
response (Table I  and Fig. 5). 
Localization  of ~Cr-labded  Thymus Cells in ALG-treated  Mice.--It  was  of L9 
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FIG. 3. Percentage of PFC remaining after in vitro incubation with different concentrations 
of ALG/A (O----O) and ALG/B (O  O) in the presence of complement. 
TABLE I 
PFC Produced in the Spleens of ALG-Treated Mice after Injection of SRBC and Thymus Cells 
Pretreatment 
ALG/A 
AL G  /B 
NIL 
Route o5 
SRBC injec- 
tion 
i.p. 
i.p. 
i.v. 
i.v. 
i.p° 
i.p. 
i.v. 
i.v. 
LV. 
LV. 
i.p. 
No. of thymus 
cells i.nj¢cted 
LV. 
lO  s 
Nil 
Nil 
IO  s 
10  8 
Nil 
Nil 
10  s 
Nil 
5 X  10  7 
Nil 
~0. Of 
mice in  Peak  PFC per spleen (-4- sE) 
group 
5 
6 
10 
9 
5 
6 
10 
8 
10 
5 
5 
12,800  +  4,270  l 
11,000  4-  2,288~ "~ 
30,100 ~- 3,6s4~ j 
64,956  4-4- 7,893,1 
16,280  4-  2,703  l 
9,5334-:t:  959fl 
,8, o  +  1,863  / 
65,700  .4- 9,986J L 
154,909  4-  14,690~f 
140,800  4-  27,733J~ 
142,600  4-  14,270 ) 
Significance level 
NS 
P  <  0.01 
P  <  0.01 
NS 
P  <  0.01 
P  <  0.01 
P  <  0.001 
NS 
NS 
interest  to determine  whether  treatment  with ALG affected the  distribution 
of injected thymus cells and particularly the extent of their localization in the 
spleen.  For  this  purpose,  50  million  51Cr-labeled  thymus  cells  were  injected 
into  normal  mice  and  mice  pretreated  with  ALG/A  24  hr  previously.  The 
localization of radioactivity was determined  6  hr later.  Approximately equal 
amounts  of  radioactivity  were  detected  in  the  circulation  in  mice  of  both 
groups. In the spleens of ALG-treated mice,  the amount of radioactivity was 861 
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only half that recorded in the spleens of normal mice. Somewhat more radio- 
activity was present in the liver and lungs of ALG-treated mice than of normal 
mice (Fig. 6). 
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FIG. 4. PFC produced in the spleens of normal mice (O  O) and of ALG-treated mice 
injected intravenously with SRBC alone (•  I), or together with either lO  s thymus cells 
(A  A) or 2 X  10  7 spleen cells (~ ID. Each point represents the mean of determina- 
tions on 4-10 mice. The sz of the means are indicated by the vertical bars. 
Hemolysin Pique-Forming Cells Produced in Irradiated Mice Injected witk 
Spleen Cells from ALG-Treated Mice.--The results obtained in Table I  can be 
interpreted  to mean that  the spleens of ALG-treated mice were deficient in 
thymus-derived cells.  Further  support for this contention would be obtained 
ff it could be shown that irradiated recipients of spleen cells from ALG-treated 
donors produced fewer PFC in response to SRBC than irradiated recipients of 
the  same number  of normal spleen  cells,  and  that  additon  of  thymus  cells 
could reverse this deficiency. Accordingly, 10 million spleen cells from normal Inoculum 
6- 
SRBC 
2 X  10  7 spleen cells +  SRBC 
l0  s bone marrow cells q- SRBC 
No. of mice 
in group 
10 
6 
3 
Peak PFC per spleen (4- sz) 
18,540  4-  1,863 
66,670  4-  11,850 
22,133  4-  2,599 
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TABLE II 
PFC Produced in the Spleens of ALG/B-Treated Mice after Intravenous Injextion of SRBC and 
either Spleen or Bone Marrow Cells 
3.  t/,  , 
2  4  ; 
DAYS  AFTER SRBC INJECTION 
FIO. 5. PFC produced  in  the  spleens of normal  mice after an  intravenous  injection  of 
SRBC alone (O  ....  O) or together with 5 X  107 thymus ceils (&  A). Each point repre- 
sents  the mean of determinations  made on five mice. The s~ of the means are indicated  by 
the vertical bars. 
or ALG-treated  mice  were  injected  intravenously  together with  SRBC  into 
two groups of heavily irradiated syngeneic recipients. As can be seen in Fig. 7 
and  Table  III,  the  response  was  lower in  the  recipients  of cells from ALG- 
treated  donors.  By adding 50 million thymus  cells to  spleen cells from these W.  3".  MARTIN AI~TD .]'. ~'.  A.  P.  MILLER  863 
donors, the response was raised to a value similar to that obtained in recipients 
of normal spleen cells.  By contrast,  50 million bone marrow cells did not en- 
hance the response. 
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FIG. 6. Localization of radioactivity in the blood and in various organs of normal and ALG- 
treated mice injected with 51Cr-labeled thymus cells 6 hr previously. The values represent 
the mean of determinations on four normal and eight ALG-treated mice. 
In  other  experiments,  50 million  thymus  ceils  were mixed with  different 
numbers of normal spleen cells ranging  from half a million  to 20 million  and 
injected intravenously together with SRBC into irradiated  syngeneic recipi- 
ents. Thymus ceils did not enhance the response obtained with normal spleen 
ceils throughout this dose range (Fig. 8). 864  CELL TO CELL INTERACTION  IN IMI~UNE RESPONSE.  IV 
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DAYS  AFTER  IRRADIATION 
FIG. 7. PFC produced in the spleens of irradiated mice injected intravenously soon after 
irradiation with SRBC and either 5 X  l0  T thymus cells ([3  [3),  107 normal spleen cells 
(O  O), l0  T spleen cells from ALG-trcated mice (e  •  e), or a mixed inoculum of 10  ~ 
spleen cells from ALG-trcated mice and 5 X  107 thymus cells (A"  A). Each point repre- 
sents the mean of determinations on 4-20 mice. The sE of the means are indicated by the 
vertical bars. 
It is known  that nonthymectomized irradiated mice protected with hemo- 
poiefic cells, such  as  those  in bone  marrow  and  spleen of both  normal  and 
neonatally thymectomized donors, begin to recover their capacity to respond 
to SRBC after a period of 1-2 wk, and normal responsiveness is achieved after 
5  wk.  By contrast,  only partial recovery occurs in mice thymectomized prior 
to irradiation and given either bone marrow from normal mice or spleen from W.  J.  MARTIN  AND  J.  F.  A.  P.  MILLER  865 
neonatally thymectomized donors. Injection of normal spleen cells however, 
immediately confers some immunological capacity, presumably by providing 
immunologically competent cells already present in  normal  spleen  (15).  An 
experiment was  thus  set  up  to  determine whether  spleen  cells  from ALG- 
treated mice could in time adoptively restore the response to SRBC in thymec- 
tomlzed irradiated hosts  to the level achieved by normal spleen cells.  Both 
TABLE  IH 
PFC Produced in the Spleens of Irradiated Mice after Intravenous Injection of SRBC, Thymus, 
or Bone Marrow Cells, and Spleen Cells from Normal or ALG-Treated Mice 
Inoculum 
l0  T  normal spleen  cells  -k SRBC 
107 normal spleen  cells  -b 5 X 10  7 thymus 
cellt  +  SRBC 
10  7 normal spleen cells +  5 X 10  7 marrow 
cells +  SRBC 
10  T  spleen cells from ALG/A-treated mice -k 
SRBC 
10  7 spleen cells from ALG/A-treated mice q- 
5 X 107 thymus cells q- SRBC 
107 spleen cells from ALO/B-treated mice -b 
SRBC 
107 spleen cells from ALG/B-treated mice -l- 
5 X  107  thymus cells  +  SRBC 
107  spleen  cells  from ALG/B-treated mice + 
5 X  107  marrow cells  +  SRBC 
5 X 10  z thymus cens ~  SRBC 
No. O| 
mice in 
group 
21 
18 
5 
20 
16 
4 
Peak PFC per  spleen 
(-~  sz) 
1500 -4- 187~ 
1818 +  244j  ] 
1444 -~ 202 
289 4-  81} 
1114 -4-  11 
173 -4-  21} 
1415  -4-  19 
330  :t:  108 
25 q-  9 
Significance  level 
NS 
NS 
P  <  0.001 
P  <  0.001 
thymectomized and nonthymectomized irradiated mice were given 10 million 
normal spleen cells, 10 million spleen cells from ALG-treated mice, or 10 million 
normal bone marrow cells. The mice were tested for their ability to respond 
to SRBC either immediately, or 2-4 wk later. The peak PFC response of mice 
challenged immediately after irradiation occurred on day 7 (Fig. 7) while that 
of  irradiated mice challenged 2-4 wklater occurred on day 4 (unpublished work). 
The results are shown in Fig. 9. In nonthymectomized mice the responses, at 
2-4  wk  posfirradiafion,  were  essentially  similar  whether  the  mice  received 
normal spleen cells,  spleen cells from ALG-treated mice, or normal bone mar- 
row cells.  On the other hand, the response of thymectomized irradiated mice 
given normal spleen cells remained significantly higher than that of mice given 866  CELL  TO  CELL  ItqTERACTION  IN  ~  ILESPONSE.  IV 
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FIG. 8. PFC produced  in the spleens of irradiated mice injected intravenously soon after 
irradiation with varying numbers of normal spleen cells with (A) or without (O) the addition 
of 5 X  10  7 thymus cells. 
spleen cells from ALG-treated donors. The partial recovery in the latter mice 
was no greater than that in mice given only bone marrow cells. 
Hemolysin Plaque-Forming Cells Produced in Irradiated  Mice Injected  with 
Spleen Cells Incubated  with ALG In  Vitro.--ALG had  no  apparent  effect in 
vivo either on hemolysin-forming cells or on their precursors. Similarly ALG/A W.  J,  MARTIN AND  J.  1  ~  A.  P.  MILLER  867 
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FIG. 9. PFC produced in the spleens of nonthymectomized irradiated (  ) and thymecto- 
mized irradiated  (m)  mice given spleen cells from normal  (O) or ALG-treated  (e) mice, 
or bone marrow ceils from normal mice (A). The recipients were challenged with  SRBC 
immediately after irradiation and cell transfer, or 2-4 wk later.  Each point represents the 
mean of determinations made on four to eight mice. The s~. of the means are indicated by the 
vertical bars. 
did not affect plaque formation by hemolysin-forming cells in vitro (Fig. 3). 
The  following experiment was  performed  in  order  to  see  whether  ALG/A 
would  affect  antibody-forming cell  precursors  in vitro.  Normal  spleen cells 
were incubated at 37°C for 15 min in the presence of ALG/A at a  concentra- 868  CELL  TO  CELL  INTERACTION  IN  YMMUNE RESPOI~SE.  IV 
tion of 100 #g/ml. The cells were washed twice and then 10 million spleen cells 
were injected together with SRBC into irradiated recipients with or without 
5  X  107 thymus ceils. The number of PFC in the recipients' spleens was deter- 
mined 7 days later and compared with that in mice given normal spleen cells 
incubated in the absence of ALG. Thymus ceils did not significantly elevate 
the response of spleen cells incubated in vitro with ALG (Table IV). Thus, it 
appears that antibody-forming cell precursors can be eliminated from a popu- 
lation of spleen cells exposed to ALG in vitro. This is in contrast to the effect 
of ALG in vivo which is exerted selectively on thymus-derived cells. 
TABLE  IV 
PFC Produced in the Spleens of Irradiated Mice Injected ugth Spleen Cells 
Preineubated In Vitro with ALG/A 
Inoculum 
l0  T  normal spleen cells -b SRBC 
l0  T  normal spleen cells -]- 5 X l0  T  thymus 
cells -I- SRBC 
10  v spleen cells preincubated with ALG -b 
SRBC 
10  ~ spleen cells preincubated with ALG -}- 
5 X l0  T  thymus cells +  SRBC 
NO. of 
mice in 
group 
7 
4 
8 
5 
Peak PFC per spleen 
(± ss) 
1301  4-  149~ 
1159  ~  166f~ 
109  ±  27 
/  344 -4-  88 
Significance  level 
NS 
P  <  0.001 
NS 
DISCUSSION 
The immune  response of mice  to SRBC  requires a  participation  by both 
thymus-derived  cells  and  bone  marrow-derived  antibody-forming cell  pre- 
cursors (6, 7). The ability of thymus cells alone to restore to near-normal the 
reactivity of ALG-treated  mice  demonstrates  that  these  mice  are  deficient 
primarily in thymus-derived ceils.  The failure to obtain complete restoration 
of the response might indicate that ALG has also some effect in vivo, on anti- 
body-forming cell precursors. This possibility appears unlikely for the follow- 
ing reasons: (a) bone marrow failed to increase the responsiveness to SRBC in 
both ALG-treated mice and in irradiated recipients of spleen cells from At, G- 
treated donors;  (b)  ALG did  not exert any immunosuppressive effect when 
given to mice after  SRBC,  that is presumably after the interaction between 
thymus-derived cells and antibody-forming ceil precursors had occurred; and 
(c) thymus cells restored the peak PFC response to SRBC in irradiated recipi- 
ents of spleen cells from ALG-treated donors to a level similar to that observed 
in irradiated recipients of normal spleen cells. The fact that the PFC response 
was not completely restored to normal may therefore result not from any sig- 
nificant effect of ALG on PFC precursors, but from other effects on the spleen. W.  J.  MARTIN  AND  J.  F.  A.  P.  m-rr.~v:R  869 
Thus the diminished  localization  of 51Cr-labeled thymus cells in  the spleens 
of these mice suggests that  some damage may have occurred in this  organ. 
Since  previous work had  shown  that  lymphocytes, preincubated with ALG 
in vitro, were rapidly eliminated from the circulation (14), the present finding 
that labeled cells remained circulating indicates that free ALG was no longer 
present in effective concentrations 24 hr after injection. 
Levey and Medawar (16)  observed that 200 million  thymus cells given to 
ALS-treated mice 25 days after skin grafting,  did not curtail graft survival. 
Thymus cells injected systemically do not localize to any significant  extent in 
the peripheral lymph nodes (17)--the  predominant site where sensitization to 
skin grafts occurs (18, 19). The inability of thymus cells to hasten the rejection 
of skin grafts might simply be linked to a failure of these cells to make contact 
with graft antigens.  Similarly,  inadequate contact between thymus cells and 
antigen  might  explain why in  our  experiments  the PFC  response  of ALG- 
treated  recipients  of  thymus  cells  was  increased  to  a  greater  extent  when 
SRBC were given intravenously than  intraperitoneally.  Denman et al.  (20) 
reported that a mixed inoculum of 150 million cells from spleen, lymph nodes, 
and  bone marrow given intravenously did not enable ALG-treated  mice  to 
produce hemagglutlnins  in response to intraperitoneal  SRBC. In our experi- 
ments 20 million spleen cells elevated the PFC response of ALG-treated mice 
injected with SRBC intravenously. The failure of Denman et al. (20) to show 
an effect with these cells is difficult  to explain particularly since lymph node 
cells home to peripheral lymph nodes after injection (21) and are effective in 
shortening the survival time of skin grafts on ALS-treated mice (16, 22). 
Levey and Medawar (16)  observed that  a  single injection of ALS was al- 
most  incapable  of  preventing  sensitization  when  allogeneic  lymphoid  cells 
were injected intravenously, but could prevent sensitization resulting from an 
allogeneic skin graft. This was taken as evidence that ALS affected circulating 
lymphocytes to a  greater extent than lymphocytes within lymphoid organs. 
In  these experiments,  however, ALS was administered  1 day aflzr  the mice 
had received either the allogeneic cells or the skin graft. It is known from the 
present experiments and those of Berenbaum (10)  that ALG cannot depress 
the response to an injection of SRBC if it is given 1 day after antigen.  The 
situation with allogeneic lymphoid cells may well be the same. On the other 
hand,  the ability of ALS to prevent sensitization when given after the appli- 
cation of a  skin graft might well be because sensitization  in effect does not 
begin until  at least 48 hr postgrafting  (23,  24).  From our own results,  it is 
apparent that ALG depressed the PFC response to SRBC to a  greater extent 
when the antigen was given intraperitoneally than when given intravenously. 
This can be taken to indicate that ALG interferes with migration of thymus- 
derived lymphocytes from the "periphery" to the lymphoid organs.  It might 
explain  why ALG  is  particularly  effective in  prolonging  survival  of  organ 870  CELL  TO  CELL  INTERACTION  IN  IMMUNE  RESPONSE.  IV 
grafts where it is likely that sensitization occurs as a result of contact between 
circulating lymphocytes and graft antigens (25).  It is also evident from our 
experiments that ALG does not affect solely "peripheral" lymphocytes but 
also alters the cell population within lymphoid organs, as shown by the poor 
PFC response of irradiated recipients of spleen cells from ALG-treated donors. 
Levey and Medawar (16) also reported delayed recovery of reactivity against 
allogeneic skin grafts in irradiated recipients of a  mixed inoculum of spleen 
and bone marrow cells obtained from mice that had received five injections of 
ALS. They argued from their results that ALS inactivated rather than elim- 
inated  lymphoid cells  (even  those  cells  within lymphoid organs);  that  the 
progeny of ALS-treated cells  were incompetent for one or more generations; 
and that the inactivation eventually wore off in the irradiated recipient. Since, 
however, both bone marrow and spleen are a  source of stem cells which can 
differentiate to immunologically competent cells in an irradiated, nonthymec- 
tomized host (15),  their data do not exclude the more likely possibility that 
competent cells were eliminated by ALS in the donor and that reactivity in the 
irradiated recipient returned only after new immunologically competent cells 
had differentiated from stem cells provided in the inoculum. Our experiments 
employing irradiated and thymectomized irradiated recipients of spleen cells 
from ALG-treated donors clearly show the importance of using thymectomized 
recipients in this type of experiment. They show in addition that ALG did not 
damage the stem cells since the return of reactivity occurred at the same rate 
in irradiated recipients of both normal bone marrow and spleen cells from ALG- 
treated donors. The peak response in thymectomized irradiated recipients of 
normal spleen cells was not significantly different whether the mice were chal- 
lenged immediately after irradiation or  2  or 4  wk later.  In  thymectomized 
irradiated  recipients  of spleen  cells  from ALG-treated donors,  the  response 
increased as the time interval between irradiation and challenge was length- 
ened,  but was  always significantly lower  than  that  in  recipients  of normal 
spleen cells. In fact it did not increase beyond that of thymectomized irradia- 
ated mice protected with normal bone marrow. These findings do not support 
the idea that ALS temporarily inactivates lymphoid cells, whether by "blind- 
folding" or by "sterile activation" (25).  They are more consistent with the 
concept that the thymus-derived cells  are eliminated. The data we have ob- 
tained in thymectomized irradiated mice are thus in general agreement with 
the results of others showing a prolongation of the immunosuppressive effect 
of ALS in thymectomized recipients (27, 28). 
Guttmann et al. (29) reported that the suppression of the response to SRBC 
in the rat by ALG was due to the presence of anti-SRBC antibodies within the 
globulin preparation  and  not  to  antilymphocyte antibodies.  In  our  experi- 
ments, ALG/B was completely absorbed with SRBC and yet was still strongly 
immunosuppressive. This difference in the results might be due to the species 
used. Thus the response to SRBC in the rat is not depressed by neonatal thy- W.  J.  MARTIN  AND  J.  ]?.  A.  P.  MILLER  871 
mectomy (30,  31)  possibly because  SRBC  are  stronger  antigens in  the rat 
which lacks the Forssman antigen than in the mouse which is Forssman posi- 
tive (32). If ALG produces the same effect as neonatal thymectomy, then one 
would not expect it to have, in the rat, a  marked immunosuppressive effect 
with respect to the response to SRBC. Consistent with this, are our findings 
that the peak antibody response of mice to the flagella antigen of Salmonella 
adelaide was depressed neither by neonatal thymectomy nor by ALG/A.  4 
The  findings reported  here  suggest  the  generalization  that,  in  vivo,  the 
specific primary target cell for the imrrmnosuppressive activity of ALS is the 
thymus-derived  antigen-reactive  cell--the  recirculating  small  lymphocyte 
which can initiate certain immune responsesuand that the effect of ALG is to 
eliminate these cells. While the mechanism of elimination is unknown, unpub- 
lished work from our laboratory suggests that opsonization followed by phago- 
cytosis plays a  major role. We have shown that, in vitro, antibody-forming 
cells precursors can be affected by ALG although there was no evidence for 
such an effect in vivo. The selective action of ALS on thymus-derived cells in 
vivo may be linked (a)  to the specificity of the antibody raised during the 
preparation of ALS;  5 (b) to the greater susceptibility of thymus-derived cells, 
in contrast to other cell types, to the action of this  antibody; and (c)  to the 
probability that recirculating cells will be exposed to ALG more extensively 
than noncirculating cells.  From these considerations,  it would seem that the 
thymus may provide the best source of cells when attempts are made to purify 
ALG by elution methods, such as the one described by Woodruff (33). 
The capacity of thymus ceils  to  reconstitute ALG-treated mice supports 
the  concept  that  cooperation  between  bone  marrow-derived  and  thymus- 
derived cells  occurs in the immune response of mice to SRBC. The lack of 
effect of ALG on bone  marrow-derived precursors  might also  explain why 
ALS does not necessarily cause lymphopenia for, as hypothesized in a prelim- 
inary communication (14),  the  deficiency resulting from the  elimination of 
thymus-derived lymphocytes might be  offset by an excessive production of 
other types of lymphoid cells. The selective action of ALS makes it a  useful 
tool in characterizing further the functions of the thymus-derived cells. 
SUMMARY 
In this series of papers it has been shown that the immune response of mice 
to sheep erythrocytes requires  the participation of two classes  of lymphoid 
ceils. Thymus-derived cells initially react with antigen and then interact with 
4 Martin, W. J., and J. F. A. P. Miller. Influence of thymectomy and ant[lymphocyte 
globulin on the antibody response to Salmondla  addakl¢ flageUin in mice. Manuscript in 
preparation. 
Unpublished studies utilizing 12SI-labeled ALG/B have shown that thymus cells absorb 
three times as much radioactivity  as bone marrow calls and six times as much as liver or kid- 
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another  dass  of  ceils,  the  antibody-forming cell  precursors,  to  cause  their 
differentiation to antibody-forming cells. 
Antilymphocyte globulin  depressed the ability of mice to respond to sheep 
erythrocytes. This effect was  more marked  when  the  antigen  was  injected 
intraperitoneally than intravenously, and occurred only when the antilympho- 
cyte globulin was  given before or simultaneously with  antigen.  Injection of 
thymus ceils restored to near normal the ability to respond to an intravenous 
injection of sheep  erythrocytes. Spleen ceils from antilymphocyte globulin- 
treated mice gave a weak adoptive immune response in irradiated  recipients. 
The addition of thymus cells however enabled a response similar to that given 
by normal spleen cells. 
When  thymectomized irradiated recipients were used, normal spleen ceils 
continued to give a higher response to a challenge of sheep erythrocytes at 2 
and 4 wk postirradiation than did spleen cells from ALG-treated donors. This 
result is more consistent with the notion that thymus-derived target cells are 
eliminated, rather than temporarily inactivated, by antilymphocyte globulin. 
These findings  suggest  that,  in vivo,  antilymphocyte globulin acts selec- 
tively on the thymus-derived antigen-reactive ceils. 
It is a pleasure to record our thanks to Miss B. Roberts and Miss M. Juchnowski  for their 
excellent  technical  assistance. 
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